Attract and retain patients through a direct‑to‑patient telehealth program.
Amwell’s Direct‑to‑Patient telehealth modules support a wide variety of use cases, from urgent care to behavioral health, chronic care management, and follow-up care. Learn how our best in class solution results in high satisfaction for patients and clinicians alike.
Key benefits
Increase patient satisfaction and loyalty
Improve brand awareness and increase patient satisfaction by providing convenient access to healthcare. Expand your catchment area and create pathways for downstream referrals.
Lower cost of care
Reduce readmissions, ED utilization, and transports through a robust telemedicine program. Save travel time for patients and providers alike.
Increase revenue
Increase referrals for high revenue services. Establish business partnerships with employers, insurers, and provider groups to create new revenue streams.
Enhance patient outcomes
Promote compliance of treatment plans and medication adherence. Manage chronic disease through frequent touchpoints with patients.
How we do it

Custom Branded Telehealth Assets
We design your telehealth app to match the look and feel of your brand. Use our suite of SDKs to embed telehealth into existing mobile apps, patient portal, or website.

The Entire Spectrum of Care
Implement standardized clinical workflows for urgent care, behavioral health, chronic care management and a variety of other use cases.

Consumer Engagement
Leverage our in-house Engagement Services to drive telehealth visits among existing members and to bring in new patients.

EMR Integration
Allow clinicians to maintain existing workflows by integrating telehealth into Electronic Health Records.

Multiple CarePoints
Patients can access your telehealth program through mobile apps, web, kiosk, or phone. Embed telehealth in your apps using our SDK.

Clinical Supply
Leverage a diverse clinician specialty network to implement a multi-specialty telemedicine program. The Amwell Medical Group helps you provide 24/7/365 care to patients.